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Combinatorial transcription factor (TF) interactions
control cellular phenotypes and, therefore, underpin
stem cell formation, maintenance, and differentia-
tion. Here, we report the genome-wide binding
patterns and combinatorial interactions for ten key
regulators of blood stem/progenitor cells (SCL/
TAL1, LYL1, LMO2, GATA2, RUNX1, MEIS1, PU.1,
ERG, FLI-1, and GFI1B), thus providing the most
comprehensive TF data set for any adult stem/
progenitor cell type to date. Genome-wide computa-
tional analysis of complex binding patterns, followed
by functional validation, revealed the following:
first, a previously unrecognized combinatorial inter-
action between a heptad of TFs (SCL, LYL1, LMO2,
GATA2, RUNX1, ERG, and FLI-1). Second, we impli-
cate direct protein-protein interactions between
four key regulators (RUNX1, GATA2, SCL, and ERG)
in stabilizing complex binding to DNA. Third,
Runx1+/::Gata2+/ compound heterozygous mice
are not viable with severe hematopoietic defects
at midgestation. Taken together, this study demon-
strates the power of genome-wide analysis in gener-
ating novel functional insights into the transcriptional
control of stem and progenitor cells.
INTRODUCTION
Combinatorial interactions of transcription factors are key deter-
minants of tissue identity. Early recognition of this came from
overexpression experiments where, for example, the myogenic
family of transcription factors (TF) could induce muscle pheno-
type in non-muscle cells (Davis et al., 1987) or combinations of
hematopoietic TFs reprogram nonhemogenic mesoderm into
blood during development (Gering et al., 2003). The particular
power of combinatorial TF interactions has been highlighted
more recently by the derivation of induced pluripotent cells532 Cell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc.through expression of pluripotency-associated TFs in differenti-
ated cells (Takahashi and Yamanaka, 2006), as well as the trans-
differentiation of pancreatic exocrine cells into insulin-secreting
b-cells (Zhou et al., 2008) and the direct conversion of fibroblasts
to functional neurons (Vierbuchen et al., 2010) following exoge-
nous expression of specific trios of transcriptional regulators.
The requirement for specific TF combinations is likely to reflect
combinatorial interactions of those TFs when binding to regula-
tory elements of their target genes. In line with this hypothesis, it
has been shown that the pluripotency factors OCT4, SOX2, and
NANOG co-occupy regulatory elements of many gene loci in
embryonic stemcells (ESCs) (Boyer et al., 2005). Systematic anal-
ysis of combinatorial transcriptional control mechanisms will
require genome-wide information on combinatorial transcription
factor binding. Significant progress in this regard has been
made to further our understanding of ESCs, where genome-
wide occupancy patterns have been established for more than
a dozen TFs (Chen et al., 2008). Recent sophisticated computa-
tional analysis of these comprehensive data sets is beginning to
reveal mechanistic insights into the transcriptional programs
operating in ESCs (Gao et al., 2009). However, with the exception
of ESCs, no comprehensive TF binding data sets have been
reported for any other mammalian stem/progenitor cell types.
Hematopoiesis has long served as a model system for
studying transcriptional control of cell-fate choice and subse-
quent differentiation. Single or pairs of transcription factors can
specify differentiation of progenitor cells into distinct mature line-
ages (Laslo et al., 2006; McNagny et al., 1998; Nerlov and Graf,
1998; Nerlov et al., 1998; Spooner et al., 2009; Ye and Graf,
2007), and detailed functional analysis of individual regulatory
elements controlled by these factors has led to the identification
of specific regulatory codes such as the Gata/E-box motif in red
blood cells or the Ets/Ets/Gata motif in stem and progenitor cells
(Donaldson et al., 2005; Pimanda et al., 2007b; Wadman et al.,
1997). However, because identification of these regulatory
codes was largely based on detailed functional studies of
specific regulatory elements, it is not clear how widely relevant
they are across the whole genome nor how they would interface
with other transcription factor complexes.
The advent of ChIP-Seq technology coupling chromatin
immunoprecipitation with high-throughput sequencing has
Figure 1. Key Hematopoietic Transcription Factors Differ in the
Number of Their Genomic Targets
The number of peaks for each transcription factor was determined as outlined
in Experimental Procedures. Each peak was then allocated to be either within
a promoter, intragenic, or intergenic region. The pie chart visually shows the
distribution of the peaks across those three categories (blue, green, and red,
respectively). For lists of peaks bound by 10 TFs and genes associated with
those peaks, see Tables S1 and S2.
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factor binding a realistic undertaking. Especially when coupled
with extensive validation and sophisticated bioinformatic
analysis, these new approaches can provide novel hypotheses
on transcriptional control mechanisms. For example, our recent
ChIP-Seq analysis of the SCL/TAL1 transcription factor in the
multipotent hematopoietic progenitor cell line 7 (HPC-7) followed
by extensive validation in transgenic mice established a suitable
model system for global analysis of transcriptional programs in
early progenitor cells by providing in vivo validated links between
SCL and 15 other hematopoietic TFs. Similarly, a recent analysis
of a model cell line for terminal erythroid differentiation provided
a genome-wide view of SCL interplay with the transcriptional
regulators LDB1, GATA1, and ETO2/MTGR1 in a mature hema-
topoietic lineage (Soler et al., 2010).
Here, we report genome-wide binding profiles for ten key
hematopoietic transcriptional regulators (SCL/TAL1, LYL1,
LMO2, GATA2, RUNX1, MEIS1, PU.1, ERG, FLI-1, and GFI1B)
in hematopoietic progenitor cells. Integrated analysis of these
data sets provides a comprehensive genome-wide view of
combinatorial interactions between these ten key regulators. In
particular, multiple independent lines of evidence demonstrate
close collaboration between seven hematopoietic stem/progen-
itor cell (HSPC)-associated TFs, including functional links
between RUNX1 and other key HSPC regulators. Subsequent
in vitro and in vivo validation confirmed a previously unrecog-
nized synergism between the three central regulators of blood
stem cell development, SCL, GATA2, and RUNX1, thus demon-
strating how comprehensive analysis of genome-wide data sets
can provide novel insights into transcriptional control of stem/
progenitor cells.
RESULTS
Key Hematopoietic Transcription Factors Differ
in the Number of Their Genomic Targets
We recently reported genomic targets of the SCL transcription
factor in the multipotential model hematopoietic progenitor cell
line HPC-7 (Wilson et al., 2009). Extensive in vivo validation of
SCL-bound enhancers in transgenic mice validated HPC-7 as
an excellent model system for early hematopoietic stem/progen-
itor cells. However, because of the absence of a negative control
ChIP-Seq data set, we had limited peak identification to those
with the lowest false discovery rate, which resulted in 228 high
confidence peaks. To address this limitation, we have now
generated a new Scl ChIP-Seq data set (15,350,104 uniquely
mappable reads) together with a control IgG ChIP sample
(9,012,777 uniquely mappable reads), which allowed us to
analyze our Scl ChIP-Seq data using software tools specifically
designed to distinguish artifactual peaks found in both test and
control samples from true binding events (see Experimental
Procedures). This resulted in the identification of 7096 statisti-
cally significant peaks (see Experimental Procedures). Impor-
tantly, analysis using the new negative control sample not only
retained all except ten of the original peaks, but also allowed
us to identify more than 6,800 new genomic locations bound
by SCL in hematopoietic cells (Table S1).
We had previously shown that Gata, Ets, Runx, Gfi, and Meis
consensus binding motifs were highly overrepresented in SCL-Cbound regions (Wilson et al., 2009), suggesting cooperation
between Scl and other major hematopoietic regulators. To
directly investigate potential combinatorial interactions at
a genome-wide scale, we have now performed ChIP-Seq assays
for an additional nine transcriptional regulators of HSCs that
would be expected to bind to these motifs. LYL1, LMO2, and
GATA2 would be expected to bind to GATA-E-box sites;
RUNX1 to the Runx motifs; MEIS1 to the Meis sites; PU.1,
ERG, and FLI-1 to the Ets sites; and GFI1b to the Gfi consensus
(the latter was chosen because even though both GFI1 and
GFI1b are expressed in HSPC, GFI1b shows higher expression
levels in HPC-7 cells). Peaks of transcription factor binding
were identified using the negative control IgG sample as before
yielding 4350 LYL1, 9604 LMO2, 9234 GATA2, 5258 RUNX1,
8386 MEIS1, 22720 PU.1, 19601 FLI-1, 36137 ERG, and 8853
GFI1B (for peak coordinates, see Table S1). To characterize
the distribution of binding events across genomic features, we
determined the number of peakswithin ± 1 kb from the transcrip-
tion start sites (promoter peaks) and partitioned the remaining
peaks into those within and between genes (intragenic and inter-
genic, respectively; see Figure 1). For LYL1, LMO2, GATA2, andell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc. 533
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Genome-wide Analysis of Blood Stem Cell RegulatorsRUNX1, very few peaks were observed over promoter regions,
with the bulk of binding events more or less evenly distributed
between intra- and intergenic sites. SCL, MEIS1, PU.1, ERG,
FLI-1, andGFI1B showed binding to a larger number of promoter
regions, and again, nonpromoter peaks were evenly distributed
between intra- and intergenic regions. To facilitate use of this
very large data set for the wider community, we generated
comprehensive supplemental data, all of which can be
downloaded from our website http://hscl.cimr.cam.ac.uk/
ChIP-Seq_Data/ChIP-Seq.html. These include the following
files: (1) custom track (.wig) files to display ChIP-Seq profiles
for each of the 10 factors in genome browsers; (2) a table listing
the peak positions for all ten TFs (Table S1); and (3) a table listing
all UCSC genes indicating which (if any) of the ten factors bind to
their respective gene loci (within the body of the gene and up to
50 kb 50 and 30 intergenic flanking sequences, Table S2). This
new ten factor ChIP-Seq data set, therefore, provides a uniquely
powerful resource for the future characterization of target genes
for these ten major hematopoietic regulators as well as the
characterization of regulatory networks in HSPCs. For the
remainder of this manuscript, we illustrate how this new data
set can provide insights into combinatorial transcriptional control
mechanisms in HSPCs.
Genome-wide Analysis Identifies Preferential
Transcription Factor Binding Pairs
Having generated genome-wide maps for ten important regula-
tors of HSPCs, we reasoned that comprehensive bioinformatic
analysis of this unique data set might allow us to obtain new
insights into combinatorial transcription factor interactions.
Visual inspection of individual gene loci demonstrated a wide
variety of combinatorial binding patterns (Figure 2). For example,
the +1 HSPC enhancer of the Hhex gene (Donaldson et al., 2005)
was bound by all ten TFs (Figure 2A), whereas multiple peaks
bound by different combinations of TFs were seen in the
Zfpm1/Fog1 gene locus (Figure 2B).
Given the large scale of genome-wide data sets, inspection of
specific gene loci is completely impractical for discovering glob-
ally important combinatorial TF patterns. In order to identify such
control mechanisms, we first asked whether the frequency of
colocalization of transcription factor pairs on the same target
regions was greater than would be expected by chance, thus
indicating preferential coregulatory activities. To this end, we
determined the number of overlapping peaks for all 45 possible
pair-wise combinations (Figure 3). This analysis identified
overlapping binding events for all pair-wise combinations but
did not address whether the observed overlaps were statistically
significant. To get an estimate of the total available space for
transcription factor binding in HPC-7 cells, we performed
a ChIP-Seq experiment using an antibody against acetylated
histone H3 (Histone H3 lysine 9 and 14), which allowed us to
define 46598 regions of enriched histone acetylation. We then
determined the total number of regions that were acetylated
and/or bound by at least one of the ten factors (e.g., the union
of acetylation and transcription factor peaks), which resulted in
a total of 80,000 unique peaks. This number is similar to
the 100,000 DNase I sites reported in human CD4 T cells and
lymphoblastoid cells (Boyle et al., 2008; McDaniell et al., 2010).
100,000 was, therefore, used as an estimate of the number of534 Cell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc.potentially available regions for binding for the ten TFs. Using
the observed numbers of peaks for each of the ten factors, we
performed simulations (1000 iterations) to determine how many
regions would be expected to be co-occupied by chance for
any pair of factors. This bootstrapping exercise demonstrated
that some overlaps were much more significant than others
and that all pairs except those involving PU.1 occur more often
than expected by chance. Many of the most significant overlaps
were observed for pairs involving known partners, such as SCL/
LMO2/LYL1/GATA2, or closely related family members, such as
Erg/Fli-1. Interestingly, pairs of factors not previously thought to
collaborate showed equally high significance, particularly those
involving RUNX1 with either SCL, LYL1, LMO2, or GATA2
(Figure 3 and Figure S2).
SCL/LYL1/LMO2/GATA2 are known to bind as components of
multiprotein complexes to regulatory elements (Anguita et al.,
2004; Wadman et al., 1997), but our analysis suggests that there
may also be close collaboration between factors not previously
known to operate together, such as SCL/RUNX1, GATA2/
RUNX1, LYL1/RUNX1, and also RUNX1/LMO2. To further inves-
tigate the likelihood of cooperative TF binding, we determined
the relative distances for all pair-wise binding events taking
advantage of the fact that ChIP-Seq peak calling algorithms
are highly accurate at identifying peak summits (Zhang et al.,
2008). This analysis demonstrated that the median distance for
all 45 pairs was variable and ranged from 22 bp (LYL1 4
LMO2) to 85 bp (PU.14 GFI1b). As different members of the
same TF family (e.g., PU.1/FLI-1/ERG and SCL/LYL1) would
be expected to often bind to the same site within a given popu-
lation of cells, we grouped all ‘‘within family’’ comparisons and
then ranked all ‘‘across family’’ comparisons based on their
median distance (Figure 3B). This analysis demonstrated that
median distances between peak centers for pair wise
combinations that involved PU.1, Gfi1b, and Meis1 were larger
than those for ‘‘within family’’ comparisons, whereas all other
combinations were within the same range (Figure 3B). Reassur-
ingly, known partners were identified within this analysis, such as
SCL/LMO2, GATA2/LMO2, and GATA2/ERG or GATA2/FLI-1.
However, previously unknown potentially collaborative
binding was also identified between SCL/RUNX1 or LYL1/
RUNX1, which together highlighted a potential new HSPC regu-
latory complex composed of SCL, LYL1, LMO2, GATA2,
RUNX1, ERG, and FLI-1.
Characterization of Wider Combinatorial Interactions
among HSPC Transcription Factors
Having identified potential interplay between seven factors from
pairwise analysis, we next interrogated whether an examination
of wider combinatorial interactions would corroborate these
initial observations. To analyze combinatorial patterns in an
unbiased fashion, we performed principal component analysis
(PCA) and hierarchical clustering (see Experimental Procedures)
of all regions bound by five or more factors (Figure 4). Analysis of
the ten factor multivariate data set by PCA revealed close corre-
lation between GATA2/SCL/LYL1 and ERG/FLI-1 occupancy
patterns with RUNX1 and LMO2 situated near these two
clusters. PU.1, GFI1B, and MEIS1 binding patterns, on the other
hand, were all found to be much more separated from the other
seven factors.
Figure 2. Specific Gene Loci Exhibit a Wide Variety of Combinatorial Binding Patterns
RawChIP-Seq read datawere transformed into a density plot for each TF and loaded into theUCSCgenomebrowser as custom tracks above theUCSC tracks for
gene structure andmammalian homology. Visual inspection of gene loci showedmany different combinations of binding for the ten different transcription factors.
Displayed here are two loci that havebeen tested previously in transgenicmice (Donaldson et al., 2005;Wilson et al., 2009). (A) Hhex. (B)Zfpm1/Fog1. Screenshots
for ten additional gene loci are provided as Figure S2. Real-time PCR validation of ChIP material in HPC-7 and E11.5 FL can be found in Figure S2.
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matical approach, we also analyzed occupancy patterns using
hierarchical clustering. Interestingly, this analysis also separated
the ten factors into two major clusters separating the TFs in the
samemanner as analysis of peak summit distances from the pair
wise comparisons and PCA (e.g., MEIS1/GFI1B/PU.1 versus
LYL1/GATA2/RUNX1/SCL/LMO2/FLI-1/ERG). Taken together,
therefore, our comprehensive bioinformatic analysis suggests
that close combinatorial interactions among seven regulators
(SCL, LYL1, LMO2, GATA2, RUNX1, FLI-1, and ERG) play an
important role in HSPC transcriptional control. Although all of
these TFs are known to be important individually for HSPCs,
our unbiased bioinformatic analysis implicates all seven factors
together as being extensively involved in cooperative transcrip-
tional control.CGenome-wide Analysis of Coordinated Binding of LYL1,
SCL, LMO2, GATA2, RUNX1, FLI1, and ERG
Statistically significant pairwise co-occupancy, close proximity
of binding, and combinatorial clustering all highlighted a heptad
of transcription factors important for HSPCs (SCL, LYL1, LMO2,
ERG, FLI-1, GATA2, and RUNX1). We, therefore, investigated
co-occupancy involving these seven factors further. There
were 1015 regions where all seven factors were bound within
200 bp or less. De novo motif discovery on this set of sequences
recovered the consensus binding motifs for all seven factors, as
well as one additional overrepresented motif. We were unable
to identify a cognate binding factor for this latter motif, but
a similar motif has previously been recovered from a purely
computational genome-wide analysis of conserved noncoding
sequences (Xie et al., 2007) (Figures 5A and B). Recovery of allell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc. 535
Figure 3. Genome-wide Analysis Identifies Preferential Transcrip-
tion Factor Binding Pairs
(A) Shown at the top is the total number of peaks for each factor followed by all
45 possible pairwise combinations (number of overlapping peaks). To obtain
a measure for the significance of pairwise overlaps, bootstrapping was
performed (see Experimental Procedures) to calculate Z scores with increased
color intensity of shading indicating increasingly higher Z scores (a full color
coded legend and actual Z scores can be found in Figure S2).
(B) Box plots showing the distances (in bp on the y axis) between peak
summits for all 45 lists of pairwise overlaps from (A). Pairwise combinations
of the 10 TFs were separated into three groups: within TF families (shaded in
green), across families with median distance equal to or below that of ‘‘within
family’’ pairs (shaded in red), and across families with median distance greater
than for the ‘‘within family’’ comparisons (shaded in blue).
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data sets produced in the current study. Moreover, identification
of only a single additional motif suggests that the set of factors
analyzed in this study provides most of the regulatory context
of regions bound by the SCL/LYL1/GATA2/RUNX1/LMO2/
FLI-1/ERG heptad.
While de novomotif discovery identifies statistically overrepre-
sented motifs within a sequence collection, it does not directly536 Cell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc.address the question of motif presence/absence or the presence
of motif combinations in individual sequences. To address this
issue, we mapped Ets, GATA, E-box, and Runx consensus
sequences across all regions bound by the seven factors and
performed hierarchical clustering to recover potential combina-
torial patterns. This analysis demonstrated that the vast majority
of heptad-bound peaks contained GATA and Ets sites (Fig-
ure 5C). By contrast, only 76% contained an E-box and even
less (39%) contained a Runx consensus motif, indicating poten-
tially indirect binding of E-Box and RUNX transcription factors
to a significant proportion of regulatory elements. Of note,
each region contained at least one of the four motifs, and over
99% contained at least two. Taken together, this analysis dem-
onstrates that expected motifs are present in heptad-bound
regions but also suggests that RUNX1 and SCL/LYL1 may be
recruited indirectly to many elements.
The SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG
Heptad Displays Previously Unrecognized Protein-
Protein Interactions
Comprehensive analysis of our ten factor ChIP-Seq data high-
lighted a preference for SCL/LYL1/GATA2/LMO2/ERG/FLI-1/
RUNX1 to bind in close proximity to each other to specific
DNA sequences. This observation is suggestive of cooperative
binding, especially in the light of the absence of bona fide
Runx1 and Scl/Lyl1 binding motifs in a substantial number of
regions. Such cooperative binding would likely be facilitated by
extensive protein-protein interactions. Previous studies have
reported interactions between GATA2/LMO2/LYL1/SCL and
also GATA2/FLI-1/ERG, yet no interactions involving RUNX1
and other heptad members have been reported in HSPCs. To
investigate protein interactions between RUNX1 and other
complex constituents, we performed coimmunoprecipitation
(Co-IP) experiments for RUNX1, SCL, ERG, and GATA2 (Fig-
ure 6A). Following transfection of myc-tagged Runx1 and flag-
tagged Scl, lysates were immunoprecipitated using an anti-
Flag antibody, and immune complexes were analyzed using an
anti-Myc antibody to detect the presence of coimmunoprecipi-
tated RUNX1. Protein complex formation between SCL and
RUNX1 can clearly be seen in Figure 6Ai, which only shows the
presence of RUNX1 when both SCL and RUNX1 have been
expressed together. To further test whether other transcription
factors bound within the heptad could act as further docking
factors for RUNX1, additional Co-IP experiments were per-
formed. A combination of myc-tagged RUNX1 and ERG or
myc-tagged RUNX1 and GATA2 were transfected and immuno-
precipitated. Immune complexes were then analyzed using
either an anti-myc or an anti-ERG antibody (Figures 6Aii and
6Aiii, respectively). Prominent interactions between RUNX1
and GATA2/ERG were seen when the relevant TFs were
coexpressed, consistent with the notion that protein-protein
interactions facilitate binding of RUNX1 to those heptad-bound
regions that lack Runx1 consensus binding motifs (Figure 6B).
GATA2/RUNX1 Compound Heterozygous Mice
Are Not Viable with Severe Hematopoietic Defects
at Midgestation
Constituents of the new HSPC heptad, such as RUNX1 or
GATA2, are individually essential for the development of
Figure 4. Characterization of Wider Combinatorial Interactions
among HSPC Transcription Factors
(A) Principle component analysis (PCA) identifies preferential combinatorial TF
associations. All genomic regions bound by five or more TFs were listed in
a ten-column table with 0/1 indicating absence/presence of each of the 10
TFs. PCA was performed and displayed using the R software environment
(http://www.r-project.org/). The plot shown displays the first three principle
components on the x, y, and z axis, with each colored dot corresponding to
the relative location of the TF indicated on the left.
(B) Hierarchical clustering of all genomic regions bound by 5 or more TFs
based on factor occupancy patterns. Themajor partition of columns separates
the 10 TFs into two main branches, with MEIS1/GFI1B/PU.1 to the left and
SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG to the right. Each line corre-
sponds to an individual genomic region where blue/white coloring indicates
the presence/absence of the given TF. Peak regions for individual TFs were
set at a standard width of 400 bp, and after merging overlapping regions,
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Cdefinitive hematopoietic cells (Cai et al., 2000; Okuda et al.,
1996; Tsai et al., 1994; Wang et al., 1996). However, heterozy-
gous Gata2+/ and Runx1+/ mice are viable with only minor
hematopoietic phenotypes (Cai et al., 2000; Ling et al., 2004;
Rodrigues et al., 2005; Sun and Downing, 2004). Cooperative
control of important common target genes would suggest that
Gata2+/::Runx1+/ compound heterozygousmicemight display
a much more severe phenotype than animals heterozygous for
a single gene only. To investigate potential consequences of
Gata2/Runx1 compound heterozygosity,Gata2+/ and Runx1+/
micewere intercrossed (Figure 6C). Interestingly, after numerous
matings, only offspring which were heterozygous for either
Runx1 or Gata2 were viable, which occurred at a normal ex-
pected Mendelian ratio. By contrast, no Gata2+/::Runx1+/
animals were found, even though one quarter of all offspring
would be expected to be compound heterozygous (p = 0.004).
These results, therefore, demonstrate that Runx1+/ and
Gata2+/ function as classical synthetic lethal alleles, which are
widely recognized as genetic evidence of buffering relationships
between genes that function in common pathways.
To examine a possible hematopoietic phenotype of
Gata2+/::Runx1+/ compound heterozygous mice, colony
assays were performed on fetal livers (FL) from embryonic (E)
day 12.5 to determine the total number of clonogenic progenitor
cells (colony forming unit-culture [CFU-C]) per FL (Figure 6D). As
reported previously, CFU-Cs were compromised in Runx1+/
and Gata2+/ fetal liver when compared with wild-type (data
not shown). Interestingly, the number of CFU-Cs was reduced
even further in fetal livers from compound heterozygous
embryos (Figure 6D), which was paralleled by a significant
reduction in overall cellularity (see Figure S3). Furthermore,
gene expression analysis demonstrated the expected reduc-
tions in Gata2 and Runx1 levels for heterozygous samples and
expression changes specific for the Gata2+/::Runx1+/
compound heterozygous samples for some GATA2/RUNX1
targets, such as Meis1, Lyl1, Zfpm1/Fog1, Scl/Tal1, Gfi1b, and
Tet2 (see Figure S3). Whether any of these expression changes
are responsible for the phenotype of Gata2+/::Runx1+/
compound heterozygous embryos will be the subject of future
investigations. Taken together, genetic analysis allowed us to
identify interplay between two of the most powerful regulators
of HSPC function and, therefore, demonstrate the power of
comprehensive bioinformatic analysis of large genome-scale
data sets for generating new biological insight.Integrated Analysis of the Ten Factor ChIP-Seq
Resource with External Data Generates
New Hypotheses
The utility of a resource, such as the ten-factor ChIP-Seq data
set described here, ultimately depends on how readily it can
be accessed by other scientists to analyze their own data and
gain novel insights. To provide a couple of vignettes of the types
of analysesmade possible, we present below integrated analysisthe average size was 460 bp ± 260 bp. PCA and hierarchical clustering identify
overlapping specific multifactor associations, such as the FLI1/ERG/LMO2
triplet or the LYL1/GATA2/RUNX1/SCL/LMO2/FLI-1/ERG heptad. (See
Table S3 for list of heptad peaks).
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Figure 5. Motif Analysis Highlights the Core Regulatory Context of the Regions Bound by the SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG
Heptad
(A) De novo motif discovery performed on the set of regions bound by the SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG heptad identified Ets, GATA, E-box, and
Runx motifs precisely corresponding to the four motifs that would be expected for these seven factors.
(B) De novo motif discovery also highlighted one additional novel motif with no match to known TF binding motifs but significant similarity to a motif of unknown
function (LM90) identified through genome-wide computational analysis of noncoding conserved sequences (Xie et al., 2007).
(C) Hierarchical clustering of all regions bound by the SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG heptad based on the presence (white) or absence (red) of
expected consensus DNA binding motifs. Consensus binding sites were mapped using TFBSSearch (Chapman et al., 2004). A significant proportion of regions
did not contain Runx (TGYGGT) and/or E-box (CANNTG) consensus bindingmotifs, whereas most regions contain GATA and Ets (GGAW) sites. (See Table S4 for
list of peaks and associated genes which do not contain either an E-box or a Runx motif).
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and single factor ChIP-Seq data. Given the wealth of high quality
gene expression profiles generated by other labs, we first asked
whether the 927 genes next to peaks bound by the heptad
showed positive enrichment for HSC-specific expression. To
this end, we performed gene set enrichment analysis (GSEA)
by loading microarray expression data from the hematopoietic
fingerprints database (Chambers et al., 2007) and the GNF
Gene Atlas (Wu et al., 2009) into the standalone GSEA program
(http://www.broadinstitute.org/gsea/) and then used the 927
genes next to heptad-bound peaks as the query gene set. The
heptad gene set showed highly significant enrichment for HSC
specific expression with both data sets (See Figure 7A), which
was not seen with three randomly chosen control gene sets538 Cell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc.(Figure S4). Moreover, Gene Ontology analysis demonstrated
that a substantial proportion of the 927 heptad targets are
involved in transcriptional control, signaling, cell death, and cell
cycle (Figure 7B). These results, therefore, suggest that the
heptad target gene set (see http://hscl.cimr.cam.ac.uk/
ChIP-Seq_Data/ChIP-Seq.html) represents a rich source of
potentially new regulators of HSCs.
We next explored the value of integrating single-factor ChIP-
Seq data with our ten-factor resource. Given that SCL/GATA
complexes were originally discovered between SCL and the
erythroid factor GATA1 (Osada et al., 1995), we asked whether
there are any potential correlations between regions bound by
GATA1 in erythroid cells and those bound by SCL and its ortho-
log LYL1, as well as GATA2, in HPC-7 cells (Figure 7C). A recent
Figure 6. The SCL/LYL1/GATA2/RUNX1/LMO2/FLI-1/ERG Heptad
Displays Previously Unrecognized Protein-Protein as Well as
Genetic Interactions
(A) Identification of protein-protein interactions between RUNX1-SCL,
RUNX1-GATA2 and RUNX1-ERG. Expression constructs were transfected
into 293T cells and putative protein interactions assayed by coimmunoprecipi-
tation/western blot analysis. (Ai) aFLAG immunoprecipitation (SCL), followed
by western blot using aMYC-tag antibody (RUNX1), demonstrates coimmuno-
precipitation of Runx1 by the aSCL (Flag) antibody. Awestern blot of lysates on
the right is shown as expression control. (Aii) aGATA2 immunoprecipitation,
followed by western blot using aRUNX1 (myc), demonstrates coimmunopreci-
pitation of Runx1 by the aGATA2 antibody. (Aiii) aMYC immunoprecitation
(Runx1), followed by western blot using a-ERG, demonstrates coimmunopre-
cipitation of ERG by the aRUNX1 (myc) antibody.
(B) Schematic of heptad proteins bound to DNA. Previously known protein
complexes are shown bound to DNA, and the newly identified links between
RUNX1 and SCL/GATA2/ERG are indicated by green arrows. The order of
proteins shown is for illustrative purposes rather than reflecting a particularly
common arrangement of binding sites.
(C) Expected and actual numbers of progeny from the Runx1+/ 3 Gata2+/
crosses. The failure to obtain live Runx1+/::Gata2+/ compound heterozygote
animals is highly significant (p = 0.004, c2 test).
(D) Colony assays on fetal livers from Runx1+/, Gata2+/ and Run-
x1+/::Gata2+/ E12.5 embryos. The data shown correspond to three, four,
and six livers, respectively, each analyzed in duplicate. Fetal livers from
compound heterozygous embryos give rise to fewer colonies than those
heterozygous for just a single gene. (See Figure S3 for differences in cellularity
of E12.5 fetal livers and qRT-PCR expression analysis of WT, Runx1+/,
Gata2+/, and Runx1+/::Gata2+/ fetal liver samples).
Figure 7. Integration of the Ten-Factor ChIP-Seq Resource with
External Data
(A) Gene set enrichment analysis (GSEA) demonstrates highly significant HSC
specific expression for the 927 candidate target genes of the SCL/LYL1/
GATA2/RUNX1/LMO2/FLI-1/ERG heptad. GSEA was performed using stan-
dard settings with two independent expression profiling compendia (Cham-
bers et al., 2007; Wu et al., 2009). The graphical outputs show enrichment
(green curve) of the heptad gene set along ranked lists of all genes ordered
based on their HSC-specificity of expression in the two data sets.
(B) Analysis of putative gene function for 927 heptad target genes reveals an
abundance of genes involved in transcriptional control and signaling.
(C) SCL, LYL1, andGATA2 binding combinations in HPC-7 cells (Venn diagram
showing the numbers of peaks bound by combinations of SCL, LYL1, and
GATA2).
(D) Peaks bound by both SCL and GATA2 in HPC-7 cells are commonly bound
by GATA1 in erythroid cells. The bar chart shows the proportion of all regions
shown in (C) that are bound by GATA1 in erythroid cells (GATA1 peak data
taken from Cheng et al. [2009]); S, SCL; L, LYL1; G, GATA2.
(E) Gene set enrichment analysis (GSEA) identifies subsets of genes next to
peaks bound by both SCL and GATA2 with erythroid-specific expression.
Neighboring genes were determined for the SG, SL, LG, and SLG peak
categories from (D), and GSEA was performed using standard settings.
Erythroid specificity of gene expression was determined by comparing
erythroid expression to the eight other mature cell types present in the hema-
topoietic fingerprints database (Chambers et al., 2007). (See Figure S4 for
GSEA analysis with control gene sets).
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Genome-wide Analysis of Blood Stem Cell Regulatorsgenome-wide ChIP-Seq analysis of Gata1 in the erythroid model
cell line G1E-ER4 identified 14,351 peaks bound by GATA1 in
erythroid cells (Cheng et al., 2009). We used this data set to
ask what proportion of the regions bound by combinations ofCSCL, LYL1, and GATA2 in HPC-7 would, later on in differentia-
tion, be bound by GATA1. As shown in Figure 7D, those regions
bound by both GATA2 and SCL in HPC-7 aremuchmore likely to
be bound by GATA1 than any of the other subsets. In contrast toell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc. 539
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commonly functions in SCL/GATA1 containing multiprotein
complexes. Our data, therefore, suggest that these functional
differences between SCL and LYL1 are already apparent in the
set of target regions bound differentially by SCL and LYL1 in
progenitors. Moreover, our results are consistent with the notion
that a significant proportion of those regions bound later on by
SCL/GATA1 are already ‘‘primed’’ by SCL/GATA2 binding in
progenitors.
To further corroborate potential priming of erythroid loci by
SCL/GATA2, we determined the genes next to peaks bound by
SCL/GATA2, SCL/LYL1, LYL1/GATA2, and SCL/LYL1/GATA2
and performed gene set enrichment analysis. Comparison of
the various peak classes demonstrated that only those genes
next to peaks bound by SCL and GATA2 (and, therefore, more
likely to be bound by GATA1 later on) showed a modest but
nevertheless significant enrichment for erythroid specific
expression (Figure 7E). This analysis illustrates, therefore, how
integrated analysis of ChIP-Seq peak regions might be utilized
to predict gene function (e.g., that SCL has a major erythroid
phenotype, whereas LYL1 does not). Moreover, by linking differ-
entially-bound ChIP-Seq peaks to neighboring genes, this anal-
ysis also provides possible candidate target genes responsible
for the different functions of Scl and Lyl1. Taken together, there-
fore, the above examples demonstrate that the ten-factor ChIP-
Seq resource reported here can be integrated readily with
external data, such as expression or ChIP-Seq profiling, to
provide a wealth of novel hypotheses.
DISCUSSION
Identification of the ‘‘rules’’ that govern gene expression in stem
cells is of fundamental scientific and clinical significance. Here,
we report genome-wide binding patterns for ten key regulators
of HSPCs. Comprehensive bioinformatic analysis of combinato-
rial binding profiles suggested new direct functional links
between some of these vital regulators of HSC function, which
were validated using both cell biological/biochemical as well
as knockout mouse in vivo approaches.
Extracting Biological Insights from ChIP-Seq Analysis
Single-protein ChIP-Seq studies reporting long lists of binding
peaks often provide only limited scientific insights because there
are far too many putative candidate target genes to provide
specific new biological functions for the upstream regulator
under investigation. The challenge, therefore, remains to
develop widely applicable strategies for extracting biological
meaning from genome-wide ChIP-Seq data. Studies in lower
model organisms, such as yeast and Drosophila, have demon-
strated that the true power of genome-wide TF binding studies
may only be revealed by studying multiple factors together. For
example, determination of genome-wide binding patterns for
a near-full complement of yeast transcription factors has served
as an important cornerstone for the development of regulatory
network models of unprecedented scale and substantial predic-
tive power (Lee et al., 2002). In addition, a genome-wide survey
of five TFs over a time series of 15 developmental stages of
Drosophila mesoderm development demonstrated that spatio-
temporal gene expression patterns could be predicted with540 Cell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc.accuracy from clustered TF binding patterns (Zinzen et al.,
2009). Similarly, a computational framework to predict absolute
as well as differential gene expression from comprehensive
mouse ESC ChIP-Seq data collections has recently been
proposed (Ouyang et al., 2009), and a comprehensive resource
of ESCs modified to express affinity-tagged transcription factor
proteins has recently been reported (Nishiyama et al., 2009).
The study reported here demonstrates that comprehensive
bioinformatic analysis of multifactor ChIP-Seq data has the
power to reveal new insights into combinatorial transcriptional
control mechanisms in complex mammalian settings.
Apart from the clear limitations of single-factor surveys, another
important consideration for ChIP-Seq studies is the homogeneity
of the starting population, which presents particular challenges
with rare and heterogeneous adult stem/progenitor cells. The
success of downstream bioinformatic analysis heavily depends
on sample homogeneity, and therefore, recent studies using
even much less challenging experimental systems, such as
mature erythroid or T cells, have opted for the use cell line systems
(Cheng et al., 2009; Fujiwara et al., 2009; Soler et al., 2010; Yu
et al., 2009). Importantly, we had previously validated Scl-bound
regions in the multipotential progenitor cell line HPC-7 as bona
fide early hematopoietic enhancers using extensive transgenic
mouse studies (Wilson et al., 2009). These demonstrated that 10
out of 11 regions boundbyScl had fetal liver activity. Four of these
ten (situated in theErg,Gfi1b,Klf2, andNfe2 loci, respectively) are
bound by all seven factors, and all four not only have fetal liver
activity, but also display specific staining within the midgestation
dorsal aorta region (data not shown) where HSCs emerge at this
time point during mouse embryogenesis (de Bruijn et al., 2000).
Further evidence of the validity of our experimental systemcomes
from our analysis of the genes next to peaks bound by the newly
identified heptad of SCL, LYL1, LMO2, GATA2, RUNX1, ERG,
and FLI-1. Gene set enrichment analysis (Subramanian et al.,
2005) demonstratedhighly significant enrichment ofgenesspecif-
ically expressed in HSCs, as well as signaling and transcriptional
regulatory proteins and was, therefore, consistent with the notion
thatgenescontrolledby thisheptadarecritical regulatorsofHSPC
function. Taken together, therefore, the data presented here
suggest that integrated analysis of ChIP-Seq results for multiple
factors has the potential to identify the key downstreammediators
of cellular phenotypes in complex mammalian systems.
Identification of Transcriptional Control Mechanisms
in HSPCs
Initial insights into gene regulatory mechanisms in HSPCs came
from studies of regulatory elements specifically active in HSPCs,
such as the Scl +19 or RUNX1 +23 enhancers (Landry et al.,
2008; Nottingham et al., 2007; Sa´nchez et al., 1999). Detailed
functional analysis demonstrated synergistic activation by
protein complexes containing the GATA factor GATA2 and Ets
factors FLI-1 or ERG (Go¨ttgens et al., 2002). Subsequent compu-
tational analysis based on evolutionarily conserved TF binding
motifs identified three structurally related elements with similar
in vivo activity leading to the hypotheses that an Ets/Ets/Gata
regulatory code plays a significant role in HSPC transcriptional
control (Donaldson et al., 2005; Pimanda et al., 2007a). However,
because of their short length and degeneracy, TF consensus
binding sequences occur many more times in mammalian
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genome-wide computational characterization of transcriptional
target sites has remained an elusive proposition. The data pre-
sented here show that multi-TF ChIP-Seq provides a much
more promising route toward gaining a comprehensive view of
transcriptional control mechanisms. Indeed, the most compel-
ling reason why computational screens will struggle lies in the
absence of recognized consensus binding sites in many regions
that are nevertheless bound by the relevant TFs in vivo, as
observed here for SCL/LYL1 and RUNX1.
Absence of conventional binding sites suggests tethering by
other factors. This is precisely what was shown previously
through a series of elegant studies where GATA1 was implicated
into recruiting SCL to DNA in erythroid cells because a mutant
Scl protein devoid of its own DNA binding domain could be
detected on regions also bound by GATA1 (Kassouf et al.,
2008). Given that Runx consensus binding motifs were absent
in an even greater proportion of heptad-bound regions than
E-boxes, we postulated that RUNX1 might also be recruited to
DNA by interacting with other TFs. However, it was not known
whether components of SCL/GATA2 complexes can interact
with RUNX1 and, thus, contribute to its tethering to DNA.
In this study, we provide evidence not only for biochemical but
also genetic in vivo interaction between RUNX1 and compo-
nents of SCL/GATA2 complexes. Bioinformatically informed
functional validation, therefore, provided previously unrecog-
nized links between some of the most powerful regulators of
HSC fate.
Combinatorial Control Mechanisms in HSPCs
The potential for different combinatorial interactions within
complex transcriptional regulatory networks is truly immense.
Even with only ten factors such as the set reported in this study,
there are 210 (1,024) different possible binding patterns based on
simple present/absent calls for each of the ten factors. In reality,
the situation is going to be much more complex still; not only
because additional factors will play a role but also because
quantitative effects are likely to be important (e.g., regions bound
strongly by both SCL and PU.1 may be functionally distinct from
those bound more strongly by SCL than PU.1). For the current
study, we focused our analysis on pairwise binding as well as
those regions bound by five or more factors. However, the
data set readily permits analysis of any other combinatorial
pattern that may be of interest to the wider community, including
any one of the 120 possible three-way and 210 possible four-way
combinations. The data presented here, therefore, represent
a platform for very substantive future investigations into the
function of ten critical regulators of HSPC function.
When faced with the prospect of having to explore potentially
huge numbers of combinatorial patterns such as the 1024
possible occupancy patterns for the 10 factors studied here, it
is salient to bear in mind that rigorous statistical analysis of the
experimental data can reduce significantly the number of
patterns when used as a means of prioritization. For example,
of the 1024 patterns possible with our ten factors, 221 are found
much more often than would be expected by chance (p < 0.01),
and importantly, many of these ‘‘overrepresented’’ patterns are
closely related. Integrated analysis taking into account for
example expression patterns or biological functions of genesCassociated with specific categories of peaks should serve to
further prioritize hypotheses for subsequent experimental
testing.
With respect to the particular combinatorial interaction
between RUNX1 and GATA2/SCL complexes explored here, it
is noteworthy that despite their apparent functional differences
during early hematopoietic development (Lancrin et al., 2009),
recent studies are consistent with overlapping functions once
the hematopoietic program is established. Deletion of RUNX1
in adult bonemarrow causes expansion of immature progenitors
with a concomitant reduction of long-term HSC activity (Grow-
ney et al., 2005), and Runx1+/ mice have increased numbers
of progenitors yet reduced numbers of LT-HSCs when
compared with wild-type mice (Sun and Downing, 2004).
At the same time, increased levels of GATA2 induce quiescence
of HSCs (Tipping et al., 2009) and SCL has also recently been
reported to be a positive regulator of HSC quiescence (Lacombe
et al., 2010). Taken together, therefore, these observations are
consistent with the notion that RUNX1, GATA2, and SCL collab-
orate by jointly controlling a set of genes critical for setting the
balance between quiescence and proliferation of HSCs. Given
that loss of function mutations of Runx1 have been found in
several types of leukemia (Osato, 2004), identifying the molec-
ular mechanisms responsible for controlling the expression of
such critical target genes in normal cells will have important
implications for our understanding of the molecular conse-
quences of aberrant transcriptional control in hematopoietic
malignancies.
The fundamental importance of combinatorial transcriptional
control of development is particularly well documented through
studies in model organisms such as sea urchin and Drosophila.
Of note, the Drosophila Gata and Runx factors Serpent and
Lozenge control key stages of blood development (Lebestky
et al., 2000) and a series of elegant experiments demonstrated
both genetic as well as direct protein-protein interactions
between Serpent and Lozenge (Waltzer et al., 2003). Moreover,
interactions between RUNX1 and GATA1 have been identified
as a potentially important transcriptional mechanism in mega-
karyocytic cells (Elagib et al., 2003; Wu et al., 2009; Xu et al.,
2006). These observations, therefore, not only emphasize the
deep evolutionary conservation of interactions between Gata
and Runx proteins but also highlight the potential for combinato-
rial interactions between different members of these two
transcription factor families in different cellular contexts. It will
be interesting to investigate to what extent larger combinatorial
interactions such as the SCL/LYL1/GATA2/RUNX1/LMO2/FLI-
1/ERG heptad identified here may be involved in controlling tran-
scription in these other lineages.
Concluding Remarks
Here, we report the genome-wide binding profiles for ten key
transcriptional regulators of HSPCs which will be of major
interest to researchers studying any one of these ten factors.
Moreover, generation of a unified data set from a single cell
type represents an important prerequisite to performing sophis-
ticated integrated analysis of combinatorial TF interactions. The
experimental data provided in this study serve as an illustration
of the potential power of such future investigations. Integrated
bioinformatic analysis prompted us to investigate interactionsell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc. 541
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formatic predictions not only validated the overall approach but
also provided a significant advance of our understanding of
blood stem cells by establishing previously unrecognized and
functionally important interactions between some of the most
powerful regulators of blood stem cells.
EXPERIMENTAL PROCEDURES
Chromatin Immunoprecipitation
HPC-7 cells (Pinto do O et al., 1998) were grown in Stem Cell Factor, and ChIP
assays were performed as previously described using polyclonal antibodies
against acetylated histone H3 (Milipore 06-599), SCL (Santa Cruz,
sc12984x), LYL1 (Abcam, ab30334-200), GATA2 (Santa Cruz, sc9008x),
LMO2 (R&D, AF2726), RUNX1 (Abcam, ab23980-100), MEIS1 (Santa Cruz,
sc-10599x), PU.1 (Santa Cruz, sc-352x), ERG (Santa Cruz, sc354x), FLI-1
(Abcam, ab15289-500), GFI1B (Santa Cruz, sc8559x), and control nonspecific
rabbit IgG (Sigma I5006); see Supplemental Experimental Procedures formore
details. Each sample was amplified and sequenced using the Illumina 2G
Genome Analyzer, following manufacturer’s instructions. Sequencing reads
were mapped to the mouse reference genome using MACS (Zhang et al.,
2008), converted to a density plot, and displayed as UCSC genome browser
custom tracks. Raw sequence data, custom track (.wig) files, and peak/gene
tables can be downloaded from the NCBI Gene Expression Omnibus portal
(www.ncbi.nlm.gov/geo; accession number GSE22178).
Peak Calling
For all ten transcription factors, three peak finding programs were used with
the same parameters used for each factor. Parameters for programs were
as follows: Findpeaks—default setting for ChIP-Seq analysis, peaks with
FDR < 0.05 called; Peakseq—default setting; MACS—MACS was used with
the following command line parameters: mfold = 16, t size = 35, bw = 100,
pvalue = 1e9, g size = 2,200,000,000, no lambda. The overlap from the three
programs was then taken (1 bp minimum). MACS peak coordinates were used
as reference for further analysis. Regions that lie at the end of chromosomes
that were high in repeat regions were subtracted from the high-confidence
peak coordinates. Finally, all peaks were standarized to 399 bp wide based
on MACS summits and average length of ChIP DNA fragments. Distances
between overlapping peaks from pairwise TF comparisons were calculated
and plotted as box plots using R (http://www.r-project.org/).
Analysis of Complex Binding Patterns
Principal component analysis (PCA) was used to reduce the dimensionality of
the datamatrix. Ten TFswere plotted in a 3D scatter plot, corresponding to the
first three principle components. In R, the svd function was used for PCA and
scatterplot3d for the 3D scatter plot. Hierarchical Clustering was performed on
the data matrix in R using the hclust function with default parameters.
Euclidean distance was used for distance matrix calculations, and the
‘‘complete method’’ was used for clustering.
Motif Analysis
Formotif analysis, the middle 200 bpwas taken for all peak regions, and peaks
were excluded from analysis if they had more than 60% of repetitve
sequences. For de novo motif discovery, the MEME program (Bailey and
Elkan, 1994) was used with standard settings. Matches to consensus
sequences were determined as described using TFBSSearch (Chapman
et al., 2004). To simplify the result matrix, 0 was used when there were no sites,
and 1 was used if 1 or more sites were found. The resulting matrix was clus-
tered and displayed using the heatmap function in R.
Coimmunoprecipitation Analysis
293T cells were transiently transfected with expression plasmids using
Protransfection Mammlian Transfection System (Promega) and incubated
48 hr before analysis. Cells were lysed and cleared of debris and DNA. Super-
natants were precleared with IgG and protein G-agarose beads. Then, anti-
FLAG antibody (Sigma M2, F3165), anti-GATA2 antibody (SC-9008x), or
MYC-agarose (sc-90 AC) were added to all corresponding samples. The542 Cell Stem Cell 7, 532–544, October 8, 2010 ª2010 Elsevier Inc.immune complexes were washed, boiled for 10 min in sample buffer, and
analyzed by western blot. Antibodies used for western blot are as follows:
ERG (Santa Cruz, sc354x) or MYC (Santa Cruz, sc-90).
Colony Assays
Clonogenic progenitor cells within the FL cell populations were assayed in the
colony-forming unit culture (CFU-C) assay. Cells were plated in duplicate in
35 mm culture dishes in MethoCult M3434 (StemCell Technologies, London,
United Kingdom) according to the manufacturer’s instructions. Cultures
were grown at 37C, 5% CO2, and colonies were counted after 7 days
(Nottingham et al., 2007).
ACCESSION NUMBERS
New microarray data have been deposited into the NCBI Gene Expression
Omnibus portal under the accession number GSE22178.
SUPPLEMENTAL INFORMATION
Supplemental information includes four figures, Supplemental Experimental
Procedures, and four tables and can be found online at doi:10.1016/j.stem.
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